• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

RocketBody’s ECG Fitness App For Apple Watch Raises $1M

Share:

September 10, 2019

The software combines ECG readings with artificial intelligence to deliver personalized workout guidance.

RocketBody, an app for the Apple Watch that uses ECG data and machine learning to guide workouts, has raised $1 million in new funding from Gagarin Capital and AltaIR Capital.

WHAT THEY DO

RocketBody is the product of Kickstarter and IndieGoGo campaigns that raised roughly $70,000 for its pitch of a $109 ECG wearable back in 2018. The readings from this device would inform an artificial intelligence companion app that would derive changes in the wearer’s metabolic rate and offer relevant fitness and training recommendations.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Since the release of the Apple Watch Series 4, however, the startup has pivoted to releasing an app version of its vision that’s relies on the Watch’s onboard ECG sensor. Once users manually transfer these readings into the subscription app, the service develops personalized cardio and strength workouts as well as other assistance with dieting and sleep.

WHAT IT’S FOR

The company wrote in its announcement that the new funds will be used to improve user retention and hammer out the monetization of its app.

MARKET SNAPSHOT

While RocketBody is noteworthy in its ECG-based approach, smartwatch fitness offerings have been around since well before the first Apple Watch — in fact, Asus announced a fitness watch with a built-in ECG tracker just yesterday.

Meanwhile, others like AliveCor and Cardiogram have long been focused on combining AI with ECG or other heart readings derived from wearables to inform cardio health management.

ON THE RECORD

“Last year, nearly 1.8 billion health and fitness apps were downloaded, as people all over the world turn their attention towards losing weight and staying fit. But far too often, the road to fitness isn’t just challenging, but wrought with injuries. People don’t know how to ensure recovery,” RocketBody CEO Tim Lipsky said in a statement. “I know this firsthand; I was a pro athlete until I got injured. Offering smarter, better, custom training is why RocketBody was born, and what sets us apart from the rest of the market.”

Date: September 10, 2019

Source: Terkko Navigator

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Delayed Nhs Medtech Funding Mandate Policy to Launch in AprilDelayed Nhs Medtech Funding Mandate Policy to Launch in April
  • 10 Best Life Sciences Stocks For This Year – Top Stocks – TheStreet Ratings10 Best Life Sciences Stocks For This Year – Top Stocks – TheStreet Ratings
  • AMA, Sling Health Launches Clinical Problem Database to Compile Insights from PhysiciansAMA, Sling Health Launches Clinical Problem Database to Compile Insights from Physicians
  • Veritas closes $1 billion GE Healthcare software unit buyVeritas closes $1 billion GE Healthcare software unit buy
  • COVID-19 pandemic – Oncology Cytotoxic Drug Market Research Outlook, Recent Trends and Growth Forecast 2020-2025COVID-19 pandemic – Oncology Cytotoxic Drug Market Research Outlook, Recent Trends and Growth Forecast 2020-2025
  • Drug Development Technology Leader Arisglobal Completes Acquisition of Amplexor Life SciencesDrug Development Technology Leader Arisglobal Completes Acquisition of Amplexor Life Sciences
  • Highmark Health Taps Verily to Build Digital Health Tools for Living Health ModelHighmark Health Taps Verily to Build Digital Health Tools for Living Health Model
  • Aerpio Pharmaceuticals and Aadi Bioscience Enter Into a Definitive Merger AgreementAerpio Pharmaceuticals and Aadi Bioscience Enter Into a Definitive Merger Agreement

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications